News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
144 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (184)
2 (144)
5 (162)
6 (107)
7 (309)
8 (243)
9 (171)
12 (212)
13 (134)
14 (258)
15 (267)
16 (110)
19 (118)
20 (147)
21 (149)
22 (140)
23 (133)
26 (20)
27 (148)
28 (183)
29 (192)
30 (107)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
31
Company closure
May 2, 2025
Earnings
Amgen Advocates For ‘Pro-Growth Tax Policy’ Instead of Tariffs to Boost Domestic Manufacturing
Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy instead of tariffs to promote domestic pharma manufacturing.
May 2, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Low-Price Drug Nations Catching ‘Free Ride’ on US Innovation, Report Says
No Patient Left Behind says that drug value assessments used in countries like Canada and Germany undervalue innovative medicines by 90% and mislead U.S. policymakers into thinking Americans are overpaying.
May 2, 2025
·
3 min read
·
Annalee Armstrong
Layoffs
Pliant Axes 45% of Workforce To Save Cash, Support Late-Stage Clinical Trials
Following challenges with its drug candidate bexotegrast and announcement of a limited-duration stockholder rights program, Pliant is paring back its workforce.
May 2, 2025
·
2 min read
·
Angela Gabriel
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Government
FDA to Rehire Some Travel Staff as Lapses Begin to Show:
AP
Some 20 travel staff at the FDA, who made arrangements for the regulator’s inspectors, will be getting their jobs back, as per the
Associated Press
. Some food scientists involved in testing will also be reinstated.
May 2, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
After multiple rounds of layoffs that cut Kronos down to just 10 people, the small molecule biotech has accepted a buyout offer from Kevin Tang’s Concentra Biosciences.
May 2, 2025
·
2 min read
·
Annalee Armstrong
Obesity
WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List:
Reuters
In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, which the agency decided against listing in 2023, the last time the Essential Medicines list was updated.
May 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 2, 2025
·
3 min read
Press Releases
Sanofi: Information concerning the total number of voting rights and shares - March 2025
May 2, 2025
·
1 min read
1 of 15
Next